Si su mdico lo considera necesario, puede recetarle una pluma con 1 mg o 2 mg de Ozempic
3,* * Based on 95,334 patients with or without type 2 diabetes (T2DM) who filed a prescription for GLP-1based treatment (tirzepatide, semaglutide, or liraglutide) between 2010 and 2023 for any indication
Whitney Evans, PhD, RD, Director of Scientific Affairs at Danone, said: GLP-1 medications can lead to substantial weight loss, but they can also create unique nutrition challenges as they can substantially reduce food and calorie intake but do not change essential nutrient needs
This phenomenon, known as telogen effluvium , has been reported in association with several weight loss medicines
Such work could one-day enable development of secretagogues that promote release of endogenous GLPs from human L-cells